2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary.

Catheter ablation Clinical document Electrical storm Electroanatomical mapping Electrocardiogram Expert consensus statement Imaging Premature ventricular complex Radiofrequency ablation Ventricular arrhythmia Ventricular tachycardia

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 03 2020
Historique:
pubmed: 30 1 2020
medline: 29 6 2021
entrez: 30 1 2020
Statut: ppublish

Résumé

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a variety of forms, from single premature ventricular complexes to sustained ventricular tachycardia and fibrillation. Rapid developments have taken place over the past decade in our understanding of these arrhythmias and in our ability to diagnose and treat them. The field of catheter ablation has progressed with the development of new methods and tools, and with the publication of large clinical trials. Therefore, global cardiac electrophysiology professional societies undertook to outline recommendations and best practices for these procedures in a document that will update and replace the 2009 EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. An expert writing group, after reviewing and discussing the literature, including a systematic review and meta-analysis published in conjunction with this document, and drawing on their own experience, drafted and voted on recommendations and summarized current knowledge and practice in the field. Each recommendation is presented in knowledge byte format and is accompanied by supportive text and references. Further sections provide a practical synopsis of the various techniques and of the specific ventricular arrhythmia sites and substrates encountered in the electrophysiology lab. The purpose of this document is to help electrophysiologists around the world to appropriately select patients for catheter ablation, to perform procedures in a safe and efficacious manner, and to provide follow-up and adjunctive care in order to obtain the best possible outcomes for patients with ventricular arrhythmias.

Identifiants

pubmed: 31995197
pii: 5717446
doi: 10.1093/europace/euz332
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

450-495

Informations de copyright

© 2020 The Heart Rhythm Society; the European Heart Rhythm Association, a registered branch of the European Society of Cardiology; the Asia Pacific Heart Rhythm Society; and the Latin American Heart Rhythm Society. Published by Elsevier Inc./Oxford University Press/Wiley. This article is published under the Creative Commons CC-BY license.

Auteurs

Edmond M Cronin (EM)

From the Hartford Hospital, Hartford, Connecticut.

Frank M Bogun (FM)

University of Michigan, Ann Arbor, Michigan.

Philippe Maury (P)

University Hospital Rangueil, Toulouse, France.

Petr Peichl (P)

Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Minglong Chen (M)

Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Narayanan Namboodiri (N)

Sree Chitra Institute for Medical Sciences and Technology, Thiruvananthapuram, India.

Luis Aguinaga (L)

Centro Privado de Cardiología, Tucuman, Argentina.

Luiz Roberto Leite (LR)

Instituto Brasília de Arritmia, Brasília, Brazil.

Sana M Al-Khatib (SM)

Duke University Medical Center, Durham, North Carolina.

Elad Anter (E)

Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Antonio Berruezo (A)

Heart Institute, Teknon Medical Center, Barcelona, Spain.

David J Callans (DJ)

University of Pennsylvania, Philadelphia, Pennsylvania.

Mina K Chung (MK)

Cleveland Clinic, Cleveland, Ohio.

Phillip Cuculich (P)

Washington University School of Medicine, St. Louis, Missouri.

Andre d'Avila (A)

Hospital Cardiologico SOS Cardio, Florianopolis, Brazil.

Barbara J Deal (BJ)

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Paolo Della Bella (P)

Ospedale San Raffaele, Milan, Italy.

Thomas Deneke (T)

Herz- und Gefäß-Klinik, Bad Neustadt, Germany.

Timm-Michael Dickfeld (TM)

University of Maryland, Baltimore, Maryland.

Claudio Hadid (C)

Hospital General de Agudos Cosme Argerich, Buenos Aires, Argentina.

Haris M Haqqani (HM)

University of Queensland, The Prince Charles Hospital, Chermside, Australia.

G Neal Kay (GN)

University of Alabama at Birmingham, Birmingham, Alabama.

Rakesh Latchamsetty (R)

University of Michigan, Ann Arbor, Michigan.

Francis Marchlinski (F)

University of Pennsylvania, Philadelphia, Pennsylvania.

John M Miller (JM)

Indiana University School of Medicine, Krannert Institute of Cardiology, Indianapolis, Indiana.

Akihiko Nogami (A)

University of Tsukuba, Ibaraki, Japan.

Akash R Patel (AR)

University of California San Francisco Benioff Children's Hospital, San Francisco, California.

Rajeev Kumar Pathak (RK)

Australian National University, Canberra Hospital, Canberra, Australia.

Luis C Saenz Morales (LC)

CardioInfantil Foundation, Cardiac Institute, Bogota, Columbia.

Pasquale Santangeli (P)

University of Pennsylvania, Philadelphia, Pennsylvania.

John L Sapp (JL)

Queen Elizabeth II Health Sciences Centre, Halifax, Canada.

Andrea Sarkozy (A)

University Hospital Antwerp, University of Antwerp, Antwerp, Belgium.

Kyoko Soejima (K)

Kyorin University School of Medicine, Tokyo, Japan.

William G Stevenson (WG)

Vanderbilt University Heart and Vascular Center, Nashville, Tennessee.

Usha B Tedrow (UB)

Brigham and Women's Hospital, Boston, Massachusetts.

Wendy S Tzou (WS)

University of Colorado Denver, Aurora, Colorado.

Niraj Varma (N)

Cleveland Clinic, Cleveland, Ohio.

Katja Zeppenfeld (K)

Leiden University Medical Center, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH